• Cat-intel
  • MedIntelliX
  • Resources
  • About Us
  • English
    Chinese
    French
    Japanese
    Korean
    German
    Spanish

    Musculoskeletal System Disorders Market Size

    ID: MRFR/HC/6760-HCR
    111 Pages
    Kinjoll Dey
    September 2025

    Musculoskeletal System Disorders Market Research Report Information By Type (Rheumatoid Arthritis, Osteoarthritis, Osteoporosis, Psoriatic Arthritis, Ankylosing Spondylitis), Treatment (Biologics, Corticosteroids, Physical Therapy, Protein Therapy, Composite Grafts) and End User (Hospitals and Clinics, Ambulatory Surgical Centers) - Forecast to 2032

    Share:
    Download PDF ×

    We do not share your information with anyone. However, we may send you emails based on your report interest from time to time. You may contact us at any time to opt-out.

    Musculoskeletal System Disorders Market Infographic
    $ 4,950.0
    $ 5,950.0
    $ 7,250.0

    Musculoskeletal System Disorders Size

    Musculoskeletal System Disorders Market Growth Projections and Opportunities

    The market for musculoskeletal system disorder treatments is significantly influenced by the rising prevalence of these disorders, particularly among the aging population. As people age, the likelihood of developing conditions such as osteoarthritis, rheumatoid arthritis, and osteoporosis increases, driving the demand for effective therapies. Innovations in medical technology paved way for the market topography. With regard to that, advances in diagnostics equipment and imaging technologies as well minimally transferred surgeries are those factors which facilitate quicker diagnoses and higher effectiveness of treatment results. Such innovations are appealing to the providers of healthcare together with patients, promoting market development respectively. Research and development activities persist in the pharmaceutical sector leading to widening of treatment alternatives for musculoskeletal disorders. The availability of new drugs, biologics and targeted therapies presents the patients with more options ultimately benefiting research driven pharmaceutical companies to compete in this market evolution. Market availability of musculoskeletal disorders state directly depends on the development level of healthcare infrastructure in different regions. In areas that have well developed health systems, adoption would be higher for advanced treatments and surgical interventions; further differences in access to medicare also bring variations into the market. What takes the form of global economic conditions impact on musculoskeletal disorder market. A stable economic environment can lead to increased healthcare spending, thus making it possible for the highly innovative methods being incorporated. On the other hand, economic recession might restrict healthcare budgets which in turn influence patient affordability and market dynamics. Empowerment of patient on musculoskeletal disorders and treatment options is a major market accelerator. Educational approaches as well an awareness campaigns leads to the early detection and proactive approach. They affect patient preferences, demands for certain treatments etc The scope of insurance coverage in musculoskeletal disorder treatments deeply impacts the market trends. Therefore, all-inclusive medical insurance that includes diagnostics, therapies and surgeries which means better access to more treatments will lead to an improved picture for market growth. Changing the lifestyle such as sedentary habits and poor quality of food added to increase musculoskeletal disorders. The market responds to these, lifestyle trends with preventive approach both medic as well medical non-medic insights complemented by the rehabilitation services and lifestyle interventions. The market also responds to strict drug approval regulations, medical device rules as well prescriptions. Conformity to regulatory standards ensures the safety and effectiveness of musculoskeletal disorder treatments; efficient market entry procedure benefits high-performing innovative therapies. Alliances between drug-manufacturing companies, healthcare professionals and health research organizations are helpful in the knowledge transfer as well bedrive innovation. The adoption of partnerships can be seen as a great contributor to the development into effective integrated care pathway and encourage provision of sustainable holistic solutions in musculoskeletal disorder management. The musculoskeletal disorder market is expanding in emerging economies due to improving healthcare infrastructure, rising disposable incomes, and increasing awareness. These markets present significant growth opportunities for companies entering with cost-effective and innovative solutions. Increasing emphasis on patient-centered care and improving quality of life shapes the musculoskeletal disorder market. Therapies that not only address symptoms but also enhance overall well-being gain traction, influencing treatment preferences and market trends.

    Musculoskeletal System Disorders Market Size Graph

    Market Summary

    As per Market Research Future Analysis, the global musculoskeletal system disorders market is projected to reach USD 6.07 Billion by 2032, growing at a CAGR of 6.8% from 2024 to 2032. The rising prevalence of musculoskeletal disorders, which affect 20%-33% of the global population, is a significant driver of market growth. These disorders are particularly common in low- and middle-income countries, necessitating lifelong management. The market is influenced by increasing health insurance reimbursements and a growing geriatric population, alongside lifestyle changes contributing to poor posture. However, high treatment costs and the availability of alternative therapies pose challenges to market expansion.

    Key Market Trends & Highlights

    Key trends influencing the musculoskeletal system disorders market include rising prevalence and treatment advancements.

    • Rheumatoid arthritis is the largest segment, affecting nearly 1% of the global population.
    • Osteoporosis is the fastest-growing segment, with over 75 million people affected in Europe, the US, and Japan.
    • Biologics are the fastest-growing treatment segment, driven by increased FDA approvals.
    • The Americas represent the largest regional market due to high prevalence and a robust healthcare system.

    Market Size & Forecast

    Market Size by 2032 USD 6.07 Billion
    CAGR from 2024 to 2032 6.8%
    Largest Segment Rheumatoid Arthritis
    Fastest Growing Segment Osteoporosis

    Major Players

    AB Science (France), Amgen Inc. (US), AstraZeneca (UK), Eisai Co., Ltd (Japan), GlaxoSmithKline PLC (UK)

    Market Trends

    The increasing prevalence of musculoskeletal disorders, coupled with an aging population, underscores the urgent need for innovative treatment solutions and comprehensive healthcare strategies.

    U.S. Department of Health and Human Services

    Musculoskeletal System Disorders Market Market Drivers

    Market Growth Projections

    The Global Global Musculoskeletal System Disorders Market Industry is projected to experience substantial growth over the next decade. The market is expected to reach 3.95 USD Billion in 2024 and is anticipated to grow to 7.39 USD Billion by 2035, indicating a robust upward trajectory. This growth is underpinned by a compound annual growth rate of 5.87% from 2025 to 2035, driven by various factors including technological advancements, demographic shifts, and increased healthcare spending. The market dynamics suggest a favorable environment for stakeholders, as the demand for innovative treatments and services continues to rise.

    Growing Geriatric Population

    The demographic shift towards an aging population is a significant driver of the Global Global Musculoskeletal System Disorders Market Industry. Older adults are more susceptible to musculoskeletal disorders due to age-related degeneration and decreased physical activity. According to projections, the global population aged 65 and older is expected to double by 2050, leading to an increased demand for healthcare services and interventions. This demographic trend is likely to contribute to a compound annual growth rate of 5.87% from 2025 to 2035, as healthcare systems adapt to the needs of this population, thereby expanding the market for musculoskeletal disorder treatments.

    Rising Healthcare Expenditure

    The increase in global healthcare expenditure is a notable factor influencing the Global Global Musculoskeletal System Disorders Market Industry. Governments and private sectors are investing more in healthcare infrastructure and services, particularly in developed regions. This trend is evident in the rising budgets allocated for orthopedic surgeries, rehabilitation services, and pain management therapies. As healthcare systems prioritize musculoskeletal health, the market is poised for expansion. The projected growth from 3.95 USD Billion in 2024 to 7.39 USD Billion by 2035 reflects this increasing investment in healthcare, which is likely to enhance access to necessary treatments for musculoskeletal disorders.

    Increased Awareness and Education

    There is a growing awareness of musculoskeletal disorders and their impact on quality of life, which is driving the Global Global Musculoskeletal System Disorders Market Industry. Educational campaigns and initiatives by healthcare organizations aim to inform the public about prevention, early detection, and treatment options. This heightened awareness encourages individuals to seek medical attention sooner, leading to earlier interventions and better outcomes. As a result, healthcare providers are witnessing an increase in patient consultations for musculoskeletal issues. This trend is expected to further stimulate market growth, as more individuals become proactive in managing their musculoskeletal health.

    Advancements in Treatment Technologies

    Technological innovations play a crucial role in shaping the Global Global Musculoskeletal System Disorders Market Industry. The development of minimally invasive surgical techniques, biologics, and advanced imaging technologies enhances treatment efficacy and patient outcomes. For example, the introduction of robotic-assisted surgeries has shown promising results in improving recovery times and reducing complications. As these technologies continue to evolve, they are expected to drive market growth significantly. The anticipated market value of 7.39 USD Billion by 2035 underscores the potential impact of these advancements on the industry, as they offer new avenues for addressing complex musculoskeletal conditions.

    Rising Prevalence of Musculoskeletal Disorders

    The Global Global Musculoskeletal System Disorders Market Industry is experiencing growth due to the increasing prevalence of musculoskeletal disorders. Conditions such as arthritis, osteoporosis, and back pain are becoming more common, particularly among aging populations. For instance, it is estimated that by 2024, the market will reach approximately 3.95 USD Billion, driven by the need for effective treatment options. The World Health Organization indicates that musculoskeletal disorders affect millions globally, leading to significant healthcare costs and loss of productivity. This rising burden necessitates advancements in treatment modalities, thereby propelling the market forward.

    Market Segment Insights

    Musculoskeletal System Disorders Type Insights

    Musculoskeletal System Disorders Treatment Insights

    Musculoskeletal System Disorders End User Insights

    Get more detailed insights about Musculoskeletal System Disorders Market Research Report - Forecast till 2032

    Regional Insights

    Key Companies in the Musculoskeletal System Disorders Market market include

    Industry Developments

    Future Outlook

    Musculoskeletal System Disorders Market Future Outlook

    The Global Musculoskeletal System Disorders Market is projected to grow at a 5.87% CAGR from 2024 to 2035, driven by technological advancements, increasing aging population, and rising prevalence of musculoskeletal disorders.

    New opportunities lie in:

    • Develop innovative digital health solutions for remote patient monitoring and management.
    • Invest in regenerative medicine technologies to enhance treatment efficacy and patient outcomes.
    • Expand into emerging markets with tailored musculoskeletal products and services.

    By 2035, the market is expected to demonstrate robust growth, positioning itself as a leader in healthcare innovation.

    Market Segmentation

    Report Scope

    Report Attribute/Metric Details
      Market Size   USD 6.07 Billion
      CAGR   6.80%
      Base Year   2023
      Forecast Period   2024-2032
      Historical Data   2022
      Forecast Units   Value (USD Billion)
      Report Coverage   Revenue Forecast, Competitive Landscape, Growth Factors, and Trends
      Segments Covered   Type, Treatment, End User
      Geographies Covered   North America, Europe, Asia-Pacific, and Rest of the World (RoW)
      Key Vendors   AB Science (France), AbGenomics International, Inc. (US), Alder BioPharmaceuticals,Inc. (US), Amgen Inc. (US), Lexicon Pharmaceuticals, Inc. (US), LG Chem (South Korea), OrthoTrophix, Inc. (US), Tarsa Therapeutics, Inc. (US), PhytoHealth Corporation (Taiwan), Eisai Co., Ltd (Japan), Astellas Pharma Inc. (Japan), AstraZeneca (UK), Baxter (US), GlaxoSmithKline PLC (UK)
      Key Market Opportunities   New product launches and R&D Amongst major key Players
      Key Market Drivers ·  Growing global geriatric population ·  Change in lifestyle habits leading to bad posture ·  Increasing research and development of new drugs to treat musculoskeletal disorders. ·  Rising prevalence of work-related musculoskeletal disorders. ·  Rising awareness of advanced treatment for musculoskeletal disorders. ·  Launch of new medication to manage the symptoms of chronic musculoskeletal system disorders.

    Market Highlights

    Author

    Kinjoll Dey
    Research Analyst Level I

    She holds an experience of about 6+ years in market research and business consulting, working under the spectrum of information communication technology, telecommunications and semiconductor domains. aarti conceptualizes and implements a scalable business strategy and provides strategic leadership to the clients. her expertise lies in market estimation, competitive intelligence, pipeline analysis, customer assessment, etc.

    Leave a Comment

    Latest Comments

    John Doe

    This is a great article! Really helped me understand the topic better.

    Posted on July 23, 2025, 10:15 AM
    Jane Smith

    Thanks for sharing this. I’ve bookmarked it for later reference.

    Posted on July 22, 2025, 7:45 PM

    FAQs

    At what CAGR is the musculoskeletal system disorders market projected to grow during the forecast period?

    The musculoskeletal system disorders market is projected to grow at a 6.8% CAGR between 2024-2032.

    Which region is predicted to have the largest share in the musculoskeletal system disorders market?

    The Americas are predicted to have the largest share in the musculoskeletal system disorders market.

    What will be the value of the musculoskeletal system disorders market during the forecast period?

    The musculoskeletal system disorders market is predicted to touch USD 6.07 Billion by 2032.

    Who are the key competitors in the musculoskeletal system disorders market?

    Key competitors in the musculoskeletal system disorders market include GlaxoSmithKline PLC (UK), Baxter (US), AstraZeneca (UK), Astellas Pharma Inc. (Japan), Eisai Co., Ltd (Japan), PhytoHealth Corporation (Taiwan), Tarsa Therapeutics, Inc. (US), OrthoTrophix, Inc. (US), LG Chem (South Korea), Lexicon Pharmaceuticals, Inc. (US), Amgen Inc. (US), Alder BioPharmaceuticals,Inc. (US), AbGenomics International, Inc. (US), and AB Science (France).

    Which factors may restrict the musculoskeletal system disorders market growth?

    High surgery cost may restrict market growth.

    1.  
    2. Chapter 1. Report Prologue Chapter
      1. Definition
      2. Scope of the Study
        1. Research Objective
        2. Assumptions
        3. Limitations Chapter
      3. Introduction
      4. Primary Research
      5. Secondary Research
      6. Market Size Estimation
    3. Chapter 4. Market Dynamics
      1. Drivers
      2. Restrains
      3. Opportunities
      4. Challenges
    4. Chapter 5. Market Factor Analysis
      1. Porters Five Forces Analysis
    5. Bargaining Power of Suppliers
      1. Bargaining Power of Buyers
    6. Threat of New Entrants
      1. Threat of Substitutes
        1. Intensity of Rivalry
      2. Value Chain Analysis
    7. Chapter 6. Global Musculoskeletal System
    8. Disorders Market, by Type
      1. Introduction
      2. Rheumatoid Arthritis
      3. Osteoarthritis
      4. Osteoporosis
      5. Psoriatic Arthritis
      6. Ankylosing Spondylitis
      7. Fibromyalgia
      8. Others Chapter 7. Global
    9. Musculoskeletal System Disorders Market, by Treatment
      1. Introduction
      2. Biologics
      3. Corticosteroids
      4. Physical Therapy
      5. Extracorporeal Shock Wave Therapy
      6. Protein Therapy
      7. Synthetic Bone Graft
      8. Composite Grafts
      9. Demineralized Bone Matrix
      10. Others Chapter
      11. Introduction
      12. Hospitals & Clinics
      13. Ambulatory Surgical Centers
      14. Others
    10. Chapter 10. Global Musculoskeletal System Disorders Market, by Region
      1. Introduction
      2. Americas
        1. North America
        2. Latin America
      3. Europe
        1. Western Europe
        2. Eastern Europe
      4. Asia-Pacific
        1. Japan
        2. China
        3. India
        4. Australia
        5. South Korea
        6. Rest of Asia-Pacific
      5. Middle East & Africa
    11. Chapter 11. Competitive Landscape
      1. Introduction
      2. Market Share Analysis
      3. Key Developments & Strategies
        1. Key Developments
    12. Chapter
    13. Company Profiles
      1. AB Science
        1. Company Overview
        2. Financial Overview
        3. Treatments Offered
        4. Key Developments
        5. SWOT Analysis
        6. Key Strategies
      2. AbGenomics International, Inc.
        1. Company Overview
        2. Financial Overview
        3. Treatments Offered
        4. Key Developments
        5. SWOT Analysis
        6. Key Strategies
      3. Alder Biopharmaceuticals, Inc.
        1. Company Overview
        2. Financial Overview
        3. Treatments Offered
        4. Key Developments
        5. SWOT Analysis
        6. Key Strategies
      4. Amgen Inc.
        1. Company Overview
        2. Financial Overview
        3. Treatments Offered
        4. Key Developments
        5. SWOT Analysis
        6. Key Strategies
      5. Lexicon Pharmaceuticals, Inc.
        1. Company Overview
        2. Financial Overview
        3. Treatments Offered
        4. Key Developments
        5. SWOT Analysis
        6. Key Strategies
      6. LG Chem
        1. Company Overview
        2. Financial Overview
        3. Treatments Offered
        4. Key Developments
        5. SWOT Analysis
        6. Key Strategies
      7. OrthoTrophix, Inc.
        1. Company Overview
        2. Financial Overview
        3. Treatments Offered
        4. Key Developments
        5. SWOT Analysis
        6. Key Strategies
      8. Tarsa Therapeutics, Inc.
        1. Company Overview
        2. Financial Overview
        3. Treatments Offered
        4. Key Developments
        5. SWOT Analysis
        6. Key Strategies
      9. PhytoHealth Corporation
        1. Company Overview
        2. Financial Overview
        3. Treatments Offered
        4. Key Developments
        5. SWOT Analysis
        6. Key Strategies
      10. Eisai Co., Ltd.
        1. Company Overview
        2. Financial Overview
        3. Treatments Offered
        4. Key Developments
        5. SWOT Analysis
        6. Key Strategies
      11. Astellas Pharma Inc
        1. Company Overview
        2. Financial Overview
        3. Treatments Offered
        4. Key Developments
        5. SWOT Analysis
        6. Key Strategies
      12. AstraZeneca
        1. Company Overview
        2. Financial Overview
        3. Treatments Offered
        4. Key Developments
        5. SWOT Analysis
        6. Key Strategies
      13. Baxter
        1. Company Overview
        2. Financial Overview
        3. Treatments Offered
        4. Key Developments
        5. SWOT Analysis
        6. Key Strategies
      14. GlaxoSmithKline PLC
        1. Company Overview
        2. Financial Overview
        3. Treatments Offered
        4. Key Developments
        5. SWOT Analysis
        6. Key Strategies
      15. Others Chapter 13. Appendix
      16. References
      17. Related Reports  
    14. Musculoskeletal System Disorders Market Estimates & Forecast, 2020-2027, (USD Million)
    15. 2020-2027(USD Million)
    16. by Type, 2020-2027(USD Million)
    17. Market, by Treatment, 2020-2027(USD Million)
    18. System Disorders Market, by End User, 2020-2027(USD Million)
    19. Musculoskeletal System Disorders Market, by Type, 2020-2027(USD Million)
    20. Market, by Region, 2020-2027(USD Million)
    21. System Disorders Market, by Type, 2020-2027(USD Million)
    22. Musculoskeletal System Disorders Market, by Treatment, 2020-2027(USD Million)
    23. 2020-2027(USD Million)
    24. Market, by Type, 2020-2027(USD Million)
    25. System Disorders Market, by Treatment, 2020-2027(USD Million)
    26. America: Musculoskeletal System Disorders Market, by End User, 2020-2027(USD Million) Million)
    27. 2020-2027(USD Million)
    28. by End User, 2020-2027(USD Million)
    29. Disorders Market, by Region, 2020-2027(USD Million)
    30. Musculoskeletal System Disorders Market, by Type, 2020-2027(USD Million)
    31. by End User, 2020-2027(USD Million)
    32. System Disorders Market, by Type, 2020-2027(USD Million)
    33. Musculoskeletal System Disorders Market, by Treatment, 2020-2027(USD Million)
    34. 2020-2027(USD Million)
    35. Market, by Type, 2020-2027(USD Million)
    36. System Disorders Market, by Treatment, 2020-2027(USD Million)
    37. Musculoskeletal System Disorders Market, by End User, 2020-2027(USD Million) Type, 2020-2027(USD Million)
    38. System Disorders Market, by Treatment, 2020-2027(USD Million)
    39. East & Africa: Musculoskeletal System Disorders Market, by End User, 2020-2027(USD Million)  
    40. 2020 by Country, 2020
    41. Share, by Country, 2020
    42. Market Share, by Country, 2020
    43. System Disorders Market Share, by Country, 2020
    44. System Disorders Market: Company Share Analysis, 2020 (%) Key Financials Regional Revenue
    45. PhytoHealth Corporation: Segmental Revenue Regional Revenue

    Musculoskeletal System Disorders Market Segmentation

    Market Segmentation Overview

    • Detailed segmentation data will be available in the full report
    • Comprehensive analysis by multiple parameters
    • Regional and country-level breakdowns
    • Market size forecasts by segment
    Infographic

    Free Sample Request

    Kindly complete the form below to receive a free sample of this Report

    Get Free Sample

    Customer Strories

    “I am very pleased with how market segments have been defined in a relevant way for my purposes (such as "Portable Freezers & refrigerators" and "last-mile"). In general the report is well structured. Thanks very much for your efforts.”

    Victoria Milne

    Founder
    Case Study
    Chemicals and Materials